| Financial Year |
March 31 2023 |
| Monetary Funds |
263,934,030.25 |
| Held-for-trading Financial Assets |
238,327,674.81 |
| Notes Receivable |
-- |
| Accounts Receivable |
246,809,712.84 |
| Advances to Suppliers |
8,501,480.88 |
| Other Receivables |
1,988,323.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
197,590,492.31 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,104,126.66 |
| Other Current Assets |
1,748,984.70 |
| Total Current Assets |
969,004,825.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
20,760,409.36 |
| Long-term Equity Investment |
71,503,711.46 |
| Investment Properties |
-- |
| Fixed Assetes |
284,872,638.62 |
| Under-construction Projects |
7,591,889.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
10,994,866.81 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,397,596.30 |
| Deferred Income Tax Assets |
3,625,744.57 |
| Other Non-Current Assets |
74,102,213.81 |
| Sub-Total of Non-Current Assets |
679,535,136.41 |
| Total Assets |
1,648,539,962.01 |
| Short-Term Loans |
10,009,166.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
71,279,340.21 |
| Accounts Received In Advance |
202,260.00 |
| Employee Compensation Payable |
9,347,918.30 |
| Taxes Payable |
6,298,531.04 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,719,268.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,926,118.65 |
| Other Current Liabilities |
966,792.66 |
| Sub-Total of Current Liabilities |
140,049,111.66 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,100,469.14 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
13,749,419.86 |
| Total Liabilities |
153,798,531.52 |
| Paid-In Capital(Or Share Stock) |
164,381,741.00 |
| Capital Surplus |
510,649,379.07 |
| Surplus Reserve |
85,099,286.98 |
| LESS:Treasury Stock |
25,211,455.00 |
| Undistributed Profits |
752,098,566.04 |
| Minority Stockholder's Interest |
7,590,717.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,487,150,713.09 |
| Owner's Equity（Stockholder's Equity） |
1,494,741,430.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,648,539,962.01 |
